Skip to main content

Colorado To Get $385 Million From National Opioid Suit

Colorado To Get $385 Million From National Opioid Suit

Colorado To Get $385 Million From National Opioid Suit

Introduction

The Colorado Attorney General's Office informed that Colorado will soon receive around $385 million from the three major drug distribution companies of the United States and Johnson & Johnson (J&J) as part of the nationwide opioid settlement.

The sum will be a part of the $26 billion nationwide opioid settlement. Every municipality and county in Colorado has agreed to the settlement and plan that provides the fund distribution.

The fast-paced processing of the approvals of the settlement from the local governments of Colorado depicts the seriousness and collaborative commitment to combat the opioid epidemic.

Centers for Disease Control and Prevention provided data that from 2000 to 2020 more than 7,600 Coloradans died from opioid overdoses and much more are still suffering from addiction. The data even reveals that the death toll from overdoses will outdo the last year's tally considering the growing outrage of opioids.

The maximum portion of the settlement amount will be used to conduct drug treatment programs, recovery prevention, education and harm reduction programs. As per the distribution agreement, the drug distributors will pay the settlement amount over 18 years, and J&J will pay over the schedule of nine years.

The state has even received roughly $8.2 million from a nearly $10 million settlement against McKinsey & Co. over the allegations that the company fueled the opioid epidemic for making profits. On the other hand, J&J has stated that it has discontinued the sale of opioid medications.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!